Literature DB >> 8915475

Early intervention in Parkinson's disease: epidemiologic considerations.

C M Tanner1.   

Abstract

This article examines the different forms of movement disorders, with a particular focus on Parkinson's disease. Screening strategies for Parkinson's disease are reviewed; these include biochemical measures, physiologic testing, positron-emission tomography, and early identification of symptoms by interview. Problems posed by the epidemiologic investigation of Parkinson's disease are considered.

Entities:  

Mesh：

Year:  1996        PMID： 8915475     DOI： 10.1016/s1047-2797(96)00066-x

Source DB:  PubMed          Journal:  Ann Epidemiol        ISSN： 1047-2797            Impact factor:   3.797


  3 in total

1.  Midlife migraine and late-life parkinsonism: AGES-Reykjavik study.

Authors:  Ann I Scher; G Webster Ross; Sigurdur Sigurdsson; Melissa Garcia; Larus S Gudmundsson; Sigurlaug Sveinbjörnsdóttir; Amy K Wagner; Vilmundur Gudnason; Lenore J Launer
Journal:  Neurology       Date:  2014-09-17       Impact factor: 9.910

2.  Decreased soluble Nogo-B in serum as a promising biomarker for Parkinson's disease.

Authors:  Hongming Liang; Wenyuan Guo; Honghu He; Hui Zhang; Qiongyu Ye; Qingxin Zhang; Jiajia Liao; Yuefei Shen; Jin Wang; Yousheng Xiao; Chao Qin
Journal:  Front Neurosci       Date:  2022-07-26       Impact factor: 5.152

3.  A novel multiplex assay for simultaneous quantification of total and S129 phosphorylated human alpha-synuclein.

Authors:  Natalie Landeck; Hélène Hall; Mustafa T Ardah; Nour K Majbour; Omar M A El-Agnaf; Glenda Halliday; Deniz Kirik
Journal:  Mol Neurodegener       Date:  2016-08-22       Impact factor: 14.195
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.